340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

GlaxoSmithKline Policy Threatens Asthma Care


 

Print Article

Feb. 16, 2022– Just days after President Biden spoke out in support of the 340B drug pricing program, drug giant GlaxoSmithKline (GSK) announced it will begin withholding 340B discounts starting in April for most safety-net hospitals. That action will bring the number of drug companies violating the 340B law to 14.

In 2021, GSK reported more than $45 billion in global sales, and it makes some of the top-selling drugs to treat asthma and chronic obstructive pulmonary disease (COPD). The company says its policy will not apply to community health centers and clinics that participate in 340B, but it will apply to hospitals that partner with community pharmacies to dispense drugs to their patients outside the hospital.

On Feb. 10, President Biden, speaking in Culpeper, Va., promoted his plans to curtail drug pricing in the U.S. In an event that also featured Rep. Abigail Spanberger (D-Va.), a strong 340B champion, the president said Spanberger “also has been relentless in making sure the law that’s been on the books that says pharmaceutical companies need to provide rural clinics and community health centers with discounts on prescription drugs is actually enforced. And we’re working together on that as well.”

That was the first time the president has spoken out on the 340B dispute. His administration has, however, been attempting to enforce the law, going to court to oppose several drug companies that are trying to block any enforcement actions taken against them. Three federal courts have issued decisions, with two courts ruling largely in favor of the government and one siding more with the drug companies involved. All three decisions have been appealed to higher courts, and the drugmakers have kept their policies in place while the appeals are pending.

Time for Penalties

In a statement, 340B Health President and Chief Executive Officer Maureen Testoni said, “In choosing to follow the lead of other drug companies that are violating federal law, GlaxoSmithKline will weaken the health care safety net and the patients who rely on it for care, including those with low incomes and those living in underserved rural communities.” She went on to note the GSK limits would harm safety-net hospitals caring for the 25 million Americans – including 5 million children – living with asthma. GSK said its policy will apply to Advair, Breo, Ventolin, Flovent, Trelegy, Anoro, Incruse, Arnuity, and Serevent.

The list of drug companies limiting 340B discounts now includes Eli Lilly, AstraZeneca, Sanofi, Novartis, Novo Nordisk, United Therapeutics, Boehringer Ingelheim, Merck, UCB, Amgen, AbbVie, Bristol Myers Squibb, Pfizer, and GSK. The government has sent enforcement letter to the first seven and is considering action on the others. The first six companies have also been referred to the Department of Health and Human Services Office of Inspector General for potential civil monetary fines of nearly $6,000 for each overcharge violation. Those could amount to hundreds of millions of dollars in fines for those companies. In her statement, Testoni said “the time has come” for those penalties to be imposed.

LATEST ARTICLES DELIVERED

Get new article alerts via email.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
2h

Two-thirds of the nation’s uncompensated care to patients in need is provided by #340B hospitals. That’s worth applauding and sharing. https://bit.ly/3JXsRR2 #Factsof340B #Protect340B

Reply on Twitter 1560338489362657280 Retweet on Twitter 1560338489362657280 Like on Twitter 1560338489362657280 1 Twitter 1560338489362657280
340bhealth 340B Health @340bhealth ·
5h

#340B is meeting the mission Congress intended. 340B discounts are funding access to #healthcare services and medications for patients with low incomes and those living in rural communities. http://bit.ly/3txSb9A #Protect340B

Reply on Twitter 1560291429557174273 Retweet on Twitter 1560291429557174273 3 Like on Twitter 1560291429557174273 10 Twitter 1560291429557174273
340bhealth 340B Health @340bhealth ·
24h

Whether they are from the east, west, north, or south, members of Congress from both political parties support the #Protect340B Act. Thank you @RepBarbaraLee and @AustinScottGA08 for co-sponsoring this legislation to stop discrimination against #340B providers.

2

Reply on Twitter 1560010232323080193 Retweet on Twitter 1560010232323080193 1 Like on Twitter 1560010232323080193 5 Twitter 1560010232323080193
Load More

RSS 340B Employed

  • Pharmacy 340B Technician FT/40HRS | CHRISTUS Health August 18, 2022
  • 340B Coordinator | Community Hospital August 11, 2022
  • 340b Director | SSM Health August 5, 2022
  • 340B Program Support Specialist | Secure340B July 23, 2022
  • 340B Coordinator | Aniz Inc. July 22, 2022

Copyright © 2022 · 340B Health